Menu

 

Research

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c3493 (Published 20 July 2010)
Cite this as: BMJ 2010;341:c3493

Related articles

Research: Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model

Published 27 September 2011; BMJ 343 doi: 10.1136/bmj.d5775

Data supplement

Web Extra

Published

Web Extra

Published

See more

News: HPV testing could cut cervical cancers by a third, finds study

Published 14 June 2013; BMJ 346 doi: 10.1136/bmj.f3888

Clinical Review: Managing unscheduled bleeding in non-pregnant premenopausal women

Published 4 June 2013; BMJ 346 doi: 10.1136/bmj.f3251

Feature: Targets for non-communicable disease: what has happened since the UN summit?

Published 21 May 2013; BMJ 346 doi: 10.1136/bmj.f3300

This article has been cited by other articles:

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls